Liu et al. [128] designed a liposome-encapsulated syringic acid (CA) (LP-CA) and modified it with Tf (Tf-LP-CA) for the purpose of promoting the uptake of the nanoparticles by tumor cells and improving the anti-tumor effect of chemotherapeutic drugs. This evidence concerns the gene TF and neoplasm.